BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2084194)

  • 21. Amiloride-sensitive and amiloride-insensitive kaliuresis in advanced chronic kidney disease.
    Levy Yeyati N; Fellet A; Arranz C; Balaszczuk AM; Adrogué HJ
    J Nephrol; 2008; 21(1):93-8. PubMed ID: 18264941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of fractional excretion and 24-hour urinary excretion of sodium and potassium in clinically normal cats and cats with induced chronic renal failure.
    Adams LG; Polzin DJ; Osborne CA; O'Brien TD
    Am J Vet Res; 1991 May; 52(5):718-22. PubMed ID: 1854095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adaptation to chronic potassium loading in normal man.
    Hené RJ; Koomans HA; Boer P; Dorhout Mees EJ
    Miner Electrolyte Metab; 1986; 12(3):165-72. PubMed ID: 3523191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antagonism of endogenous mineralocorticoids in normal subjects by prorenoate potassium and spironolactone.
    Levine D; Ramsay L; Auty R; Branch R; Tidd M
    Eur J Clin Pharmacol; 1976 Mar; 09(5-6):381-6. PubMed ID: 786663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of aldosterone and spirolactone on urinary sodium and potassium excretion in newborns and infants (author's transl)].
    Solc J; Knorr D
    Z Kinderheilkd; 1974 Jan; 116(2):143-52. PubMed ID: 4816159
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of aldosterone on potassium excretion during potassium chloride infusion in sheep.
    Rabinowitz L; Sarason RL; Yamauchi H
    Am J Physiol; 1985 Oct; 249(4 Pt 2):R455-61. PubMed ID: 4051031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 5 alpha-Dihydro-11-deoxycorticosterone as a mineralocorticoid agonist and antagonist: evidence for a weak mineralocorticoid as an antagonist of potent mineralocorticoids.
    Sekihara H; Yazaki Y
    J Steroid Biochem Mol Biol; 1993 Apr; 45(4):235-8. PubMed ID: 8499332
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of a simplified assay for determination of the antimineralocorticoid activity of compounds dosed in rats.
    Brandish PE; Chen H; Szczerba P; Hershey JC
    J Pharmacol Toxicol Methods; 2008; 57(2):155-60. PubMed ID: 18304838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sheep renal potassium excretion: efferent kaliuretic regulatory factors.
    Rabinowitz L; Sarason RL; Yamauchi H
    Am J Physiol; 1984 Sep; 247(3 Pt 2):F520-6. PubMed ID: 6476127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Demonstration of an intrinsic renal adaptation for K+ conservation in short-term K+ depletion.
    Ornt DB; Tannen RL
    Am J Physiol; 1983 Sep; 245(3):F329-38. PubMed ID: 6614171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Homeostatic potassium excretion in fed and fasted sheep.
    Rabinowitz L; Green DM; Sarason RL; Yamauchi H
    Am J Physiol; 1988 Feb; 254(2 Pt 2):R357-80. PubMed ID: 3344840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paradoxical potassium excretion in response to aldosterone antagonists.
    Ramsay LE; Harrison IR; Shelton JR; Tidd MJ
    Eur J Clin Pharmacol; 1977 Jan; 11(2):101-5. PubMed ID: 837961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of dexamethasone on renal electrolyte excretion in the adrenalectomized rat.
    Bia JM; Tyler K; DeFronzo RA
    Endocrinology; 1982 Sep; 111(3):882-8. PubMed ID: 7106056
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal function in the chronically cannulated fetal llama: comparison with studies in the ovine fetus.
    Wintour EM; Riquelme R; Gaete C; Rabasa C; Sanhueza E; Silver M; Towstoless M; Llanos A
    Reprod Fertil Dev; 1995; 7(5):1311-9. PubMed ID: 8848605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mineralo- and glucocorticoid effects on renal excretion of electrolytes.
    Campen TJ; Vaughn DA; Fanestil DD
    Pflugers Arch; 1983 Oct; 399(2):93-101. PubMed ID: 6647008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mineralocorticoid activity and the excretion of an oral potassium load in normal man.
    Hené RJ; Koomans HA; Rabelink AJ; Boer P; Dorhout Mees EJ
    Kidney Int; 1988 Nov; 34(5):697-703. PubMed ID: 3199680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioassay of aldosterone antagonists in normal human subjects: a relationship between the level of plasma uric acid before treatment and apparent drug responses.
    Ramsay LE; Hessian P; Tidd MJ
    Br J Clin Pharmacol; 1975 Jun; 2(3):271-6. PubMed ID: 1234508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fetal and maternal fluid balance in sheep during hyperthermia with and without water deprivation.
    Dickson KA; Harding R
    Exp Physiol; 1997 Jul; 82(4):777-89. PubMed ID: 9257118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improved method for comparative evaluation of aldosterone antagonists in healthy man.
    Casals-Stenzel J; Schmalbach J; Losert W
    Eur J Clin Pharmacol; 1977 Dec; 12(4):247-55. PubMed ID: 590311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic effects of high dose amiloride and spironolactone: a comparative study in normal subjects.
    Millar JA; Fraser R; Mason P; Leckie B; Cumming AM; Robertson JI
    Br J Clin Pharmacol; 1984 Sep; 18(3):369-75. PubMed ID: 6386025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.